 |
인쇄하기
취소
|
Ilyang’s new leukemia drug approved in Korea
Local drugmaker Ilyang Pharmaceutical said Thursday that the Korea Food and Drug Administration has approved its highly-anticipated leukemia medicine, the 18th-domestically-made medication.
The drug will be indicated for those patients who have shown a resistance to Gleevec as the second line drug, according to Ilyang officials.
The drug, known as radotinib, is believed to be 30 times mor...
The drug will be indicated for those patients who have shown a resistance to Gleevec as the second line drug, according to Ilyang officials.
The drug, known as radotinib, is believed to be 30 times mor...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.